107 related articles for article (PubMed ID: 23462454)
1. Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.
Zhu Z; Sun Z; Wang Z; Guo P; Zheng X; Xu H
J Surg Res; 2013 Jul; 183(1):177-83. PubMed ID: 23462454
[TBL] [Abstract][Full Text] [Related]
2. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 125(3):715-27. PubMed ID: 20369284
[TBL] [Abstract][Full Text] [Related]
4. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Med Oncol; 2014 Sep; 31(9):145. PubMed ID: 25097078
[TBL] [Abstract][Full Text] [Related]
5. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
6. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
[TBL] [Abstract][Full Text] [Related]
7. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas.
Xing YN; Xu XY; Nie XC; Yang X; Yu M; Xu HM; Liu YP; Takano Y; Zheng HC
Hum Pathol; 2012 Dec; 43(12):2299-307. PubMed ID: 22863086
[TBL] [Abstract][Full Text] [Related]
8. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
9. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
11. Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator.
Sun G; Wang Y; Zhu Y; Huang C; Ji Q
Acta Otolaryngol; 2011 Feb; 131(2):197-203. PubMed ID: 21105847
[TBL] [Abstract][Full Text] [Related]
12. Chemokine decoy receptors: new players in reproductive immunology.
Borroni EM; Bonecchi R; Buracchi C; Savino B; Mantovani A; Locati M
Immunol Invest; 2008; 37(5):483-97. PubMed ID: 18716935
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.
Zhang H; Hou Y; Xu L; Zeng Z; Wen S; Du YE; Sun K; Yin J; Lang L; Tang X; Liu M
Dig Dis Sci; 2016 Apr; 61(4):1080-90. PubMed ID: 26694172
[TBL] [Abstract][Full Text] [Related]
14. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors.
Zhao Z; Han F; He Y; Yang S; Hua L; Wu J; Zhan W
Eur J Surg Oncol; 2014 Oct; 40(10):1361-8. PubMed ID: 24821064
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
18. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
20. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
